Bone Marrow Failure Syndromes

Bone Marrow Failure Syndromes

Bone Marrow Failure Syndromes

On this page

BMF Basics - Marrow Meltdown Intro

Bone Marrow Failure (BMF) is a "marrow meltdown": pancytopenia (↓RBCs, ↓WBCs, ↓Platelets) with a hypocellular bone marrow. Hematopoietic stem cells (HSCs) fail to produce mature blood cells.

  • Core Problem: Deficient hematopoiesis.
  • Mechanisms:
    • Intrinsic HSC defects (genetic mutations)
    • Extrinsic insults (drugs, toxins, viruses, immune destruction)
    • Defective marrow microenvironment (stromal dysfunction)
  • Types:
    • Inherited: Fanconi Anemia, Dyskeratosis Congenita, Shwachman-Diamond Syndrome.
    • Acquired: Aplastic Anemia (idiopathic, secondary), Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndromes (MDS).
  • Key Presentation: Symptoms of cytopenias - fatigue (anemia), recurrent infections (neutropenia), bleeding/petechiae (thrombocytopenia). Bone Marrow Failure Syndromes Diagnostic Algorithm

⭐ Bone marrow biopsy showing hypocellularity (e.g., <25% cellularity for age, or <50% cellularity with <30% hematopoietic cells) is crucial for BMF diagnosis, distinguishing it from other causes of pancytopenia like hypersplenism or infiltrative disorders where marrow is often hypercellular or normocellular but ineffective (e.g., MDS).

Fanconi & DBA - Genetic Gloomies

Fanconi Anemia (FA)

  • Inheritance: Autosomal Recessive (AR); Patho: Defective DNA repair.
  • Onset: Age 5-10 yrs with progressive pancytopenia.
  • Anomalies (~75%): Skeletal (thumb/radial defects, short stature), skin (café-au-lait, pigmentary changes), renal.
  • Diagnosis: ↑ AFP, ↑ HbF. Chromosomal breakage test (DEB/MMC) is diagnostic.
  • Malignancy risk: ↑ AML, MDS, solid tumors (e.g., SCC).
  • Management: HSCT (curative), androgens, G-CSF. 📌 FANconi: Failure (pancytopenia), Anomalies, Neoplasia.

Diamond-Blackfan Anemia (DBA)

  • Inheritance: Autosomal Dominant (AD, RPS19 gene); Patho: Ribosomopathy.
  • Onset: Infancy (<1 yr) with Pure Red Cell Aplasia (PRCA); macrocytic anemia.
  • Anomalies (~50%): Craniofacial (Cathie facies), triphalangeal thumbs, cardiac defects.
  • Diagnosis: ↑ MCV, reticulocytopenia, normal WBC/platelets, ↑ HbF. BM: Erythroid hypoplasia.

    ⭐ Elevated erythrocyte adenosine deaminase (eADA) activity is a key diagnostic marker.

  • Management: Corticosteroids (1st line), transfusions, HSCT.

Genetic basis of bone marrow failure syndromes

SDS, DC & Acquired AA - More Marrow Mayhem

  • Shwachman-Diamond Syndrome (SDS)

    • Exocrine pancreatic insufficiency (steatorrhea, FTT)
    • Neutropenia (often cyclical), skeletal abnormalities (metaphyseal chondrodysplasia, short stature)
    • SBDS gene mutation; ↑ Risk of MDS/AML
  • Dyskeratosis Congenita (DC)

    • Classic triad: Reticular skin hyperpigmentation, nail dystrophy, oral leukoplakia Dyskeratosis Congenita triad: skin, nails, oral leukoplakia
    • Defective telomere maintenance (e.g., DKC1, TERC, TERT genes)
    • BMF, MDS/AML, solid tumors (SCC), pulmonary fibrosis
  • Acquired Aplastic Anemia (AA)

    • Pancytopenia + hypocellular bone marrow (<25% cellularity, or <50% if <30% hematopoietic cells) Normal vs Hypocellular Bone Marrow
    • Etiology: Idiopathic (~70%, immune-mediated), drugs (chloramphenicol), toxins (benzene), viruses (hepatitis)
    • Severe AA (SAA): BM criteria + ≥2 of:
      • ANC < 0.5 x 10⁹/L
      • Platelets < 20 x 10⁹/L
      • Reticulocytes < 1%
    • Very Severe AA (VSAA): SAA criteria + ANC < 0.2 x 10⁹/L
    • Treatment: Immunosuppression (IST: ATG + cyclosporine), HSCT

⭐ PNH clones in many AA patients predict IST response.

BMF Workup & Fixes - Lab Sleuths & Cures

  • Diagnosis:
    • CBC (pancytopenia), ↓reticulocytes, peripheral smear.
    • Bone Marrow Aspiration & Biopsy: Key! Shows hypocellularity (<25%), dysplasia; cytogenetics (e.g., monosomy 7); rules out infiltration.
  • Etiology Tests:
    • Fanconi: DEB/MMC stress test.
    • PNH: Flow cytometry (CD55/CD59).
    • Dyskeratosis Congenita: Telomere length.
  • Management:
    • Supportive: Irradiated transfusions, antibiotics, iron chelation.
    • Definitive:
      • Acquired AA: IST (ATG+Cyclosporine) or HSCT (1st line for severe/young with donor).
      • Inherited BMF: HSCT is curative.
      • Refractory AA: Eltrombopag.

⭐ Severe AA: Marrow <25% cells (or <50% if <30% hematopoietic) AND ≥2 of: ANC <0.5x10⁹/L, Plt <20x10⁹/L, Retics <1% (corrected).

High‑Yield Points - ⚡ Biggest Takeaways

  • Fanconi Anemia: AR, DNA repair defect; pancytopenia, café-au-lait spots, thumb/radial defects; ↑ AML/MDS risk.
  • Diamond-Blackfan Anemia: AD (mostly), ribosomal protein defect; pure red cell aplasia, craniofacial/thumb defects.
  • Shwachman-Diamond Syndrome: AR, SBDS gene; neutropenia, pancreatic insufficiency, skeletal issues; ↑ MDS/AML risk.
  • Dyskeratosis Congenita: Telomere defect; triad: skin pigmentation, nail dystrophy, oral leukoplakia; pancytopenia.
  • Severe Congenital Neutropenia: ELANE gene common; severe neutropenia (<200/µL), infections; ↑ MDS/AML risk.

Practice Questions: Bone Marrow Failure Syndromes

Test your understanding with these related questions

What is the best treatment option for a patient aged 65 years with severe aplastic anemia who has an HLA-compatible sibling available?

1 of 5

Flashcards: Bone Marrow Failure Syndromes

1/10

Do patients with juvenile CML have philadelphia chromosome?_____

TAP TO REVEAL ANSWER

Do patients with juvenile CML have philadelphia chromosome?_____

No

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial